Glen Harbor Capital Management’s NxStage Medical Inc. NXTM Stock Holding History

Glen Harbor Capital Management’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-3,828	Closed	-$95K	–	1324
2018 Q1	$95K	Sell	3,828 -11,594	-75%	-$282K	﹤0.01%	1161
2017 Q4	$374K	Sell	15,422 -11,044	-42%	-$291K	0.01%	760
2017 Q3	$730K	Sell	26,466 -3,300	-11%	-$88K	0.02%	479
2017 Q2	$746K	Sell	29,766 -9,922	-25%	-$246K	0.02%	481
2017 Q1	$1.06M	Hold	39,688	–	–	0.03%	395
2016 Q4	$1.04M	Buy	+39,688	New	+$982K	0.03%	369

Other funds holding NXTM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Glen Harbor Capital Management's NXTM Position: Q2 2018 in Review

Glen Harbor Capital Management sold out of NxStage Medical Inc. (NXTM) in Q2 2018, closing a stake of 3,828 shares — an estimated $95K sold.

Glen Harbor Capital Management first reported a position in NXTM in Q4 2016 and held it in 6 quarters. The position peaked at $1.06M in Q1 2017. 171 funds tracked by Wall St. Rank hold NXTM as of Q2 2018.

Glen Harbor Capital Management reported no remaining NxStage Medical Inc. position as of Q2 2018 after selling out during the quarter.
Glen Harbor Capital Management sold 3,828 NxStage Medical Inc. shares in Q2 2018, an estimated $95K.
Glen Harbor Capital Management first reported a position in NxStage Medical Inc. in Q4 2016 and held it in 6 quarters.
Glen Harbor Capital Management's NxStage Medical Inc. position peaked at $1.06M in Q1 2017.
171 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q2 2018.

Based on Glen Harbor Capital Management's 13F filing for Q2 2018, filed 13 Aug 2018.